Elsevier

Brain Research

Volume 954, Issue 2, 8 November 2002, Pages 173-182
Brain Research

Research article
Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635

https://doi.org/10.1016/S0006-8993(02)03243-2Get rights and content

Abstract

Serotonin (5-HT) 1A receptors have been implicated in a variety of conditions including, depression, suicidal behavior, and aggression. Post-mortem brain studies and in vivo imaging studies report a variety of age and sex effects on brain 5-HT1A binding. Behavioral data from 5-HT1A specific pharmacological challenges suggest a role for 5-HT1A receptors in aggression. The goal of the present study was to determine age, sex, and severity of life-time aggression effects on 5-HT1A binding potential (BP) in vivo using positron emission tomography (PET) and the high affinity 5-HT1A antagonist, [carbonyl-C-11]WAY-100635 in 12 healthy females (ages 41.0±15.7 years) and 13 healthy males (ages 39.6±15.5 years). Regions of interest included the dorsal raphe, anterior cingulate cortex, cingulate body, hippocampus, amygdala, medial prefrontal cortex (PFC), and orbital PFC. No significant correlation between age and BP was detected in any brain region. MANOVA of the first three principle components demonstrated a significantly higher BP in females compared with males (P=0.0127). Post-hoc tests confirmed sex differences (P<0.05) in the following regions: dorsal raphe, amygdala, anterior cingulate, cingulate body, medial PFC, and orbital PFC. The cerebellar volume of distribution was also significantly higher in females. There is a significant negative correlation between binding in several regions and lifetime aggression. We have replicated our post-mortem finding of higher 5-HT1A binding in females compared to males. We did not detect an age dependent decrease in binding in males or females. Lower 5-HT1A binding in more aggressive individuals is consistent with pharmacological challenge studies. Future studies should determine whether the binding is a state or trait effect.

Introduction

Serotonin (5-HT) neurons, arise from the dorsal and median raphe nuclei and innervate virtually all regions of the brain [45]. 5-HT1A receptors are somatodendritic autoreceptors in the raphe nuclei and post-synaptic receptors in the neocortex, hippocampus, and other limbic structures [7], [50]. WAY-100635, N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl) cyclohexane carboxamide, is a 5-HT1A antagonist with high affinity and selectivity for 5-HT1A receptors (KD=0.1–0.4 nM) [21], [23]. Previous in vivo imaging studies using the [C-11]WAY-100635 compound have shown an age dependent decrease in the specific to non-specific equilibrium partition coefficient (V3″) in males only [10], and in a mixed population of both males and females [47]. A larger study in males only did not replicate the age related decline using the same outcome measure [43]. Post mortem studies by our group have demonstrated greater 5-HT1A binding in females compared to males [4]. Additionally, there are several reports of a relationship between aggression and 5-HT1A receptors [12], [13], [14]. We have previously demonstrated that compartmental modeling is the best method for quantification of 5-HT1A binding [42]. In this study we wanted to determine whether: (a) decreases in V3″ with age could be replicated or if these findings reflected limitations of the method used to model the binding data, (b) post mortem sex differences in 5-HT1A receptors could be reproduced in vivo, (c) the severity of life-time aggression was correlated with brain 5-HT1A binding. The results would have implications for the design and interpretation of results of studies in clinical populations.

Section snippets

Subjects

Twelve healthy females and 13 healthy males who did not meet criteria for any Axis I diagnosis based on the Structured Clinical Interview for DSM IV (SCID I) [44], including substance abuse or dependence, and were medically well based on history, review of systems, physical examination, routine blood tests, pregnancy test, and urine toxicology, were studied after giving written informed consent. All subjects were off all medications (prescription, over the counter, or herbal) for at least 2

Results

Males and females did not differ in age, the injected dose, injected mass, or clearance of the [C-11]WAY-100635 compound (Table 1). The amount of [C-11]WAY-100635 available to bind to 5-HT1A receptors is dependent on the free fraction of [11C]WAY-100635 (the percentage of [C-11]WAY-100635 not bound to plasma proteins). There was no statistically significant difference in the free fraction between females (9.2±2.7%) and males (9.7±2.0%). There was also no age effect on the free fraction in the

Discussion

We have previously reported [42] that compartmental modeling of [C-11]WAY-100635 in healthy volunteers is preferable for quantifying 5-HT1A binding in vivo. Females have higher 5-HT1A binding potential in all brain regions, and a higher cerebellar VT. There is no age effect on binding potential in either males or females or the group as a whole. There is a significant inverse correlation between binding potential in several brain regions and severity of lifetime aggression as measured by the

Acknowledgements

This work was supported by US PHS grants NIMH P30 MH46745, MH40695 and NIMH K02-MH01603 and NARSAD. The authors would like to thank the staff of the Kreitchman PET Center and Department of Neuroscience Brain Imaging Division, Julie Arcement, Cristina Battistuzzi, and Thomas Cooper.

References (50)

  • S Lowther et al.

    5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls

    J. Affect. Disord.

    (1997)
  • L Palego et al.

    Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus

    Brain Res

    (1997)
  • E.A Rabiner et al.

    P., Cowen, P.M. Grasby, A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological,demographic, physiological, and behavioral variables

    Neuroimage

    (2002)
  • H.W.M Steinbusch

    Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminal

    Neuroscience

    (1981)
  • J Tauscher et al.

    Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET

    Neuropsychopharmacology

    (2001)
  • L Uphouse et al.

    Gender and estrous cycle differences in the response to the 5-HT1A agonist 8-OH-DPAT

    Pharmacol. Biochem. Behav.

    (1991)
  • A Abi-Dargham et al.

    SPECT measurement of benzodiazepine receptors in human brain with [123I]iomazenil: kinetic and equilibrium paradigms

    J. Nucl. Med.

    (1994)
  • A Abi-Dargham et al.

    Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility

    J. Cereb. Blood Flow Metab.

    (2000)
  • A Abi-Dargham et al.

    PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756

    Synapse

    (1999)
  • A Biegon et al.

    Serotonin receptor modulation by estrogen in discrete brain nuclei

    Neuroendocrinology

    (1982)
  • A Biegon et al.

    Modulation by estradiol of serotonin receptors in brain

    J. Neurosci.

    (1982)
  • P Blier et al.

    Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission

    Ann. N. Y. Acad. Sci.

    (1998)
  • S.C Cheetham et al.

    Brain 5-HT1 binding sites in depressed suicides

    Psychopharmacology (Berl.)

    (1990)
  • C Cidis Meltzer et al.

    Gender-specific aging effects on the serotonin 1A receptor

    Brain Res.

    (2001)
  • A.J Cleare et al.

    The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects

    Psychopharmacology (Berl.)

    (1995)
  • Cited by (280)

    View all citing articles on Scopus
    View full text